CBD oil sourced from hemp is legal all across the U.S when sold as a dietary supplement. Our full-spectrum CBD oil products, when taken daily, add CBD, as well as essential vitamins, minerals, fatty acids, terpenes, flavonoids, and other trace cannabinoids, to your healthy diet. Try one of these healthy recipes for easily adding CBD into your meals.
The benefits of CBD for anxiety have traditionally been assessed through subjective reports, like anxiety questionnaires and surveys, but recent groundbreaking research has been able to demonstrate that CBD upregulates specific neurotransmitter pathways in the brain, and changes cerebral blood flow patterns to areas of the brain linked to the symptoms of anxiety. These mechanistic changes make an even stronger case that CBD is an effective way to reduce feelings of anxiety.

All this talk about THC lands us nicely in the whole “Full Spectrum vs. Pure Isolate” debate. Once you begin shopping for CBD products, you’ll notice a lot of jargon that gets thrown around without much explanation. Now that we’ve introduced THC into the conversation, we can talk about the difference between, and relative benefits of, Full Spectrum CBD and CBD Isolate (and the lesser-known contender: Broad Spectrum).
Weight plays a role in the effects of CBD oil, and bottle size should be selected based on how much you weigh. Let’s say you weigh less than 130 pounds and desire light CBD oil effects; this means that 11 mg or less will probably suffice per dose, giving roughly 40 doses from a 450-mg concentration. If you weigh more than 230 pounds and desire strong effects, then this same concentration will supply roughly 10 doses.
“There is a great deal of confusion regarding the legal status of hemp and why these products are so readily available versus marijuana-based CBD products. In 2014, the Farm Bill stated that hemp was different from marijuana, yet the Drug Enforcement Agency’s (DEA) position is that hemp comes from the cannabis sativa plant and as such falls under the controlled substance act. In 2004, the Hemp Industry Association won a court case against the DEA from the Ninth Circuit Court of Appeals that ruled the DEA didn’t have the authority to ban hemp under the CSA. “By that federal court ruling, similar to non-scheduled hemp food products, this allows Medical Marijuana, Inc. (including  HempMeds®) to sell online and distribute to customers in the U.S. states,” said Dr. Stuart Titus, the company’s Chief Executive Officer.”
A research study posted to Addictive Behaviors shows that cannabidiol oil helps in treatment for substance abuse. According to the study, continued use of cannabidiol oil helped reduce tobacco consumption when used for 1 week. The participants in the research study randomly picked a placebo or CBD. They were then urged to use what they had picked whenever they felt like taking a cigarette. The participants with the placebo didn’t experience any decrease as opposed to the particiapnts who took CBD and decreased cigarette consumption by about 40%.

Other potential side effects include low blood pressure, lightheadedness, and drowsiness, but these have typically only occurred in patients who have exceeded doses of 1,500 mg daily for a period of 4 weeks or more; far more than the average person will need take on a daily basis for chronic pain symptoms. (In fact, the majority of CBD users claim they find an effective dose to be anywhere between 10 and 40 mg daily).
Seizure disorder (epilepsy). A specific cannabidiol product (Epidiolex, GW Pharmaceuticals) has been shown to reduce seizures in adults and children with various conditions that are linked with seizures. This product is a prescription drug for treating seizures caused by Dravet syndrome or Lennox-Gastaut syndrome. It has also been shown to reduce seizures in people with tuberous sclerosis complex, Sturge-Weber syndrome, febrile infection-related epilepsy syndrome (FIRES), and specific genetic disorders that cause epileptic encephalopathy. But it's not approved for treating these other types of seizures.

In the United States, CBD itself is not specifically listed in the United States Controlled Substances Act like the psychoactive compound, tetrahydrocannabinol (THC). The US government, which specifies which parts of cannabis plants are prohibited, excludes hemp’s “mature stalks” and “oil or cake made from the seeds” and “sterilized seeds” from its definition of “marihuana.”
So, why are companies allowed to lie and mislead users trying to purchase CBD products? This a result of the industry lacking formal regulation. This is very controversial because it opens the doors for big pharmaceutical companies and lobbyists to get away with practices that may prevent CBD from becoming easily accessible to those who need it. Hopefully, legislation like the 2018 Farm Bill will help establish competitive practices in the industry that will benefit the consumer in the long run.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).
×